Rapid Micro Biosystems In... (RPID)
2.59
-0.09 (-3.36%)
At close: Mar 31, 2025, 12:11 PM
Rapid Micro Biosystems Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 5.31M | 4.92M | 5.17M | 7.88M | 5.69M | 3.17M | 3.32M | 2.84M | 3.21M |
| Product Revenue Growth | +8.07% | -4.95% | -34.32% | +38.39% | +79.58% | -4.66% | +16.88% | -11.37% | n/a |
| Service Revenue | 2.35M | 2.08M | 1.96M | 2.31M | 2.08M | 1.83M | 1.71M | 1.53M | 1.53M |
| Service Revenue Growth | +12.88% | +6.12% | -15.29% | +11.03% | +13.75% | +7.13% | +11.83% | 0.00% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| All Other Countries Revenue | 3.97M | 2.96M |
| All Other Countries Revenue Growth | +33.98% | n/a |
| Germany Revenue | 2.12M | 2.65M |
| Germany Revenue Growth | -20.12% | n/a |
| Japan Revenue | 2.56M | 2.76M |
| Japan Revenue Growth | -7.04% | n/a |
| Switzerland Revenue | 4M | 8.77M |
| Switzerland Revenue Growth | -54.43% | n/a |
| United States Revenue | 9.88M | n/a |
| United States Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.05M | 9.45M | 8.91M | 8.7M | 9.7M | 9.93M | 9.93M | 11.26M | 11.12M | 9.89M | 9.55M | 9.12M | 8.37M | 6.75M | 5.48M | 4.93M | 3.99M | 3.18M | 3.84M |
| Selling, General, and Administrative Revenue Growth | -4.16% | +6.03% | +2.41% | -10.35% | -2.29% | n/a | -11.79% | +1.23% | +12.45% | +3.54% | +4.77% | +8.89% | +24.07% | +23.17% | +11.03% | +23.72% | +25.45% | -17.15% | n/a |
| Research and Development Revenue | 3.61M | 3.74M | 3.84M | 3.32M | 3.12M | 3.23M | 3.15M | 3.4M | 2.97M | 2.96M | 3.52M | 2.85M | 2.44M | 2.34M | 2.15M | 1.63M | 2.22M | 1.24M | 1.44M |
| Research and Development Revenue Growth | -3.61% | -2.55% | +15.79% | +6.48% | -3.62% | +2.54% | -7.35% | +14.46% | +0.27% | -15.89% | +23.47% | +16.96% | +4.45% | +8.85% | +32.12% | -26.93% | +78.78% | -13.49% | n/a |
| Sales and Marketing Revenue | 3.38M | 3.63M | 3.28M | 3.16M | 3.5M | 3.2M | 3.46M | 4.12M | 3.93M | 3.48M | 3.46M | 3.35M | 3.06M | 3.12M | 2.27M | 1.81M | 1.45M | 1.24M | 1.47M |
| Sales and Marketing Revenue Growth | -6.92% | +10.55% | +3.80% | -9.63% | +9.28% | -7.54% | -16.05% | +4.94% | +12.80% | +0.81% | +3.01% | +9.53% | -1.89% | +37.23% | +25.48% | +25.29% | +17.07% | -15.69% | n/a |